Diabetes Treatment Weblog

Posts Tagged ‘insulin therapy’

All over the world celebrated World Diabetes Day, a date important to make people aware about this disease. Organized jointly by the International Diabetes Federation (IDF, for its acronym in English) and the World Health Organization (WHO), this celebration took place on Saturday 14 November.

The World Diabetes Day is an important vehicle for all countries to ensure that people know the true magnitude of the problem of diabetes, a disease that currently affects approximately 220 million people, according to official figures published on the site WHO web.

How could it be otherwise, the secretary general of the United Nations, Ban Ki-moon issued a message in the context of World Diabetes Day, which was published in full in the official website of the international organization.

Read the rest of this entry »

Alice Posada has marked in her memory December 26, 2006, the day they discovered that her daughter Emily had diabetes type I, a metabolic disease that requires daily insulin injections.

Her daughter, then 18-months old, was rushed and spent several days in the hospital tested until doctors were able to determine the dose of insulin needed to balance your blood sugar level. “I do not understand anything, it was blank,” said Alice to voanoticias.com, who until now had no close relative with Type I diabetes

Hospital Alice and her husband came up with an idea of how the metabolism of Emilia, what dose of insulin would need daily, what kind of diet should continue and at what times I had to eat. In practice, this meant a total rethinking of their lives. Alice had to leave her job of 10 years as a clerk in a blood bank to provide care for her daughter. And over the years, she and her family learned to overcome their fears and prepare for future obstacles.

Read the rest of this entry »

Are diagnosed each year in Spain, 1,100 new cases of diabetes in children and much of it is detected late. Thus, 45% of children between 5 and 10 years who are diagnosed with diabetes also show state of ketoacidosis, a serious complication that is due to a very marked lack of insulin.

Read the rest of this entry »

Since 2007 in Germany is going a combined therapy of the drug pioglitazone with insulin. First interim analysis was recently published. These indicate that the combination in the future is both effective and safe.

The type 2 diabetes
Type-2 diabetes have a resistance of body cells to the biological effects of insulin. Once this so-called insulin resistance is too strong, does the injected insulin in a diabetes therapy is not effective enough. Be increased in these cases, the insulin sensitivity by insulin sensitizers. These sensitizers are firstly used for type-2 diabetes with marked insulin resistance, ie, in patients in whom insulin alone is insufficient. On the other hand in diabetic patients who are not the standard combination of insulin and metformin because of contraindications or intolerance can take.

Read the rest of this entry »

In Germany, a type-2 diabetes is often treated with tablets. These are relatively easy to handle and do not require intensive training as they are common for insulin users. Nevertheless, type-2 diabetes have a relatively high risk for atherosclerosis and heart disease. A new study has dealt with the question of which treatment option for type 2 diabetes cheap.

Read the rest of this entry »

The first human trials of the latest design of an artificial pancreas for people with type 1 diabetes found that the drive works without causing low blood sugar (hypoglycemia).
In the best case, this type of automated device finally released people with type 1 diabetes need injections that many each day and the constant need to check levels of blood sugar and monitor their food as appropriate.

The device, produced through a collaboration of experts from Boston University, Massachusetts General Hospital and Harvard Medical School has two hormones that are deficient among Type 1 diabetic, insulin, which prevents levels blood sugar get too high after a meal, and glucagon, a hormone that occurs naturally that prevents blood sugar levels fall too far.

Read the rest of this entry »

To understand insulin resistance, it helps to understand a little about how insulin works and its role in the body. Insulin is an essential hormone created in the pancreas, which is involved in the metabolism of sugars in the body. Without it, we can not turn the food we eat into usable energy.

When we eat something, a lot of digested food is converted into glucose, the main energy source of the body. The pancreas then responds to blood sugar levels by secreting insulin in increasing the flow of blood. Most cells in your body contain insulin receptors that help insulin bind to the cell. Once insulin binds to the cell, activate other receptor sites, allowing glucose to enter the cell and provide energy for life.

Read the rest of this entry »

Dolphins have a mechanism that allows them to control levels of blood sugar. A study of dolphins revealed genetic clues that could help scientists find new treatments for type 2 diabetes in humans.

Scientists at the National Marine Mammal Foundation of America (NMMF) found that the bottlenose dolphin (Tursiops truncatus) is resistant to insulin, the hormone that regulates glucose levels in the blood-like people suffering type 2 diabetes .

Read the rest of this entry »

A great support for anyone with diabetes, the blood glucose self-regulation. It allows the patients on a personal security because they are always informed about the level of their current value and can respond quickly if needed. The patient can then have full control his illness and thus optimize treatment outcomes. For Type-1 diabetes, the blood glucose self-regulation already considered standard therapy, while in type-2 diabetes, most commonly used with insulin treatment. The application for type-2 diabetes without insulin treatment is controversial, especially in recent times.

Read the rest of this entry »

The treatment with the new diabetes drug is useful for certain diabetes patients. The Professional Association of diabetological specialist centers in North Rhine (BdSN) indicates that the active ingredient is wrote under certain conditions should be in order then to be able to contribute positively. “Patients on their current medication are well adjusted, but have no reason now to change the medicine,” said Dr. Ulrich Nühlen from BdSN. Liraglutide is in Germany and Britain since July on the market. The drug provides for that only increases with increased blood glucose, insulin is distributed. Thus, the drug not only lowers blood glucose levels but also reduces the risk of over-or hypo.

Read the rest of this entry »